Asthma Attack Symptoms . Symptoms of an asthma attack may develop gradually or happen suddenly and can vary from person to ...

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...

The data from the real-world evidence study "Characterizing uncontrolled severe asthma in Canada (ALERT)" was recently ...

The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...

Delsym and Robitussin-DM contain the active ingredient dextromethorphan, a cough suppressant. In addition to dextromethorphan ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Patient advocacy group uses report data to push solutions on air pollution, access to medicine, health equity 2024 Asthma ...

AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint: Cambridge, UK Tuesday, October 8, 2024, 09:00 H ...

In the phase 3b BATURA trial, Airsupra—a pressurized metered-dose inhaler containing albuterol and budesonide—significantly ...

Low climate-impact corticosteroid inhalers are as effective as high climate impact inhalers for COPD and asthma outcomes, per ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

Respiratory medicine is one frontier of the global healthcare landscape which has undergone significant transformations in ...